Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Weight loss injections can be useful aids for people who are struggling to shed unwanted pounds. GLP-1 agonist jabs, like ...

The FDA has received six adverse event reports connected to this specific lot of Ozempic (all submitted by Novo Nordisk), but ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Donald Trump, at 78, is aggressively pursuing his second term, marked by significant policy changes and a noticeable physical ...

As per the study, it turns out that the Glucagon-like Peptide-1, the GLP-1 receptor agonists, the active components present in drugs like Ozempic could influence the dopamine system. For good mood ...

Eli Lilly shares are now positive for the year, up 10% since the start of January.

The secret of the president’s dramatic weight loss is the talk of the White House, our must-read newsletter The Swamp reveals.